Latest news from SEQENS Group

All news

Events General PERSONAL CARE Press release Products & Technologies Protéus SD-CSR

SEQENS announces the appointement of a new CEO

France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued

Read more

3rd Franco-German Technology Dialogue

Sodium Carbonate & Silicate: key ingredients in “green tire” production

Seqens is proud to announce the official partnership between Alganelle and Sederma for the development of a future cosmetic ingredient.

Biocatalysis: a science in permanent technological evolution

Protéus by Seqens, expertise partner of the virtual congress Protein Engineering Connect

Seqens supports the French Business Climate Pledge initiative

CPhI Webinar series : Enzymes & Biocatalysis for Green Chemistry

Essential molecules’ production in France: our investment plan

Seqens’ commitment to reducing its carbon footprint

4 years of partnership with the Arche de la Vallée association

Nitrosamines: quick mobilization of a multidisciplinary team in response to regulatory changes

Our products contribute to the 17 United Nations SDGs

1 2 3 4 5 6 … 11

Contact